#Gene_Editing

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

ERS Genomics Unveils Early Access Express License for Innovators ERS Genomics has introduced its Early Access Express License to provide founders and teams affordable access to CRISPR/Cas9 technology for research purposes.

ERS Genomics Unveils Early Access Express License for Innovators #Ireland #Dublin #Gene_Editing #CRISPR #ERS_Genomics

Thiard News@F4F

@newsen.bsky.social

3 months ago

Origin Agritech's Hi3 Gene Editing Technology Recognized as Major Progress in Chinese Agricultural Science 2025 Origin Agritech's cutting-edge Hi3 gene editing technology has been recognized as one of the top advancements in Chinese agricultural science for 2025, showcasing its commercial potential.

Origin Agritech's Hi3 Gene Editing Technology Recognized as Major Progress in Chinese Agricultural Science 2025 #China #Beijing #Origin_Agritech #Gene_Editing #Hi3_technology

Thiard News@F4F

@newsen.bsky.social

3 months ago

Moligo Technologies and Cellectis Unveil Groundbreaking DNA Technology for Gene Editing Moligo Technologies, in collaboration with Cellectis, reveals promising results for non-viral gene editing using enzymatically synthesized single-stranded DNA, as published in Nature Communications.

Moligo Technologies and Cellectis Unveil Groundbreaking DNA Technology for Gene Editing #Sweden #Stockholm #Gene_Editing #Cellectis #Moligo

Thiard News@F4F

@newsen.bsky.social

4 months ago

World's First Gene-Editing Therapy for Hyperlipidemia Approved CorrectSequence Therapeutics announces a groundbreaking gene-editing treatment targeting APOC3 for hyperlipidemia, marking a significant medical milestone.

World's First Gene-Editing Therapy for Hyperlipidemia Approved #China #Shanghai #Gene_Editing #CorrectSequence #APOC3

Thiard News@F4F

@newsen.bsky.social

6 months ago

Cancer Gene Therapy Market Anticipated to Reach $19.97 Billion by 2033 with Rapid Growth The cancer gene therapy market is set to expand significantly, projected to reach $19.97 billion by 2033, with advances in treatment methods fostering growth.

Cancer Gene Therapy Market Anticipated to Reach $19.97 Billion by 2033 with Rapid Growth #United_States #Austin #Immunotherapy #Gene_Editing #Cancer_Gene_Therapy

Thiard News@F4F

@newsen.bsky.social

6 months ago

iNtRON Bio Makes Strides in Gene Editing with New IMPA™ Technology Applications iNtRON Bio recently filed two patents for its novel IMPA™ gene editing technology, aiming to revolutionize bacteriophage applications in medicine.

iNtRON Bio Makes Strides in Gene Editing with New IMPA™ Technology Applications #South_Korea #Seoul #Gene_Editing #iNtRON_Bio #IMPA_technology

chitownhustler_actual

@chitownhustler.bsky.social

7 months ago

What Makes PROTEUS a Biological AI Machine? Meet PROTEUS: A virus-inspired machine that could transform gene-editing tools and mRNA medicines. Can AI be made of mammalian cells?

“PROTEUS can produce mammalian-specific adaptations that we wouldn’t have predicted or evolved in other systems…”

Gee, what could possibly go wrong? #Science #Biology #Gene_Editing
spectrum.ieee.org/proteus-mamm...

Thiard News@F4F

@newsen.bsky.social

8 months ago

O'Shaughnessy Ventures Awards $100K Fellowship for Aging Biology Research The O'Shaughnessy Fellowship honors Benjamin Arya with $100,000 to enhance gene-engineering tools aimed at combating aging.

O'Shaughnessy Ventures Awards $100K Fellowship for Aging Biology Research #Gene_Editing #O'Shaughnessy_Ventures #Benjamin_Arya

Thiard News@F4F

@newsen.bsky.social

8 months ago

Pusan National University Develops Tool Enhancing CRISPR Off-Target Predictions for Diverse Genetic Variants Researchers from Pusan National University have unveiled a groundbreaking web tool designed to enhance CRISPR off-target predictions through individual genetic variations, improving the safety and accuracy of gene editing.

Pusan National University Develops Tool Enhancing CRISPR Off-Target Predictions for Diverse Genetic Variants #South_Korea #Pusan_National_University #Busan #Gene_Editing #CRISPR

Thiard News@F4F

@newsen.bsky.social

9 months ago

YolTech Therapeutics Achieves FDA Clearance for Revolutionary Gene-Editing Therapy YOLT-101 YolTech Therapeutics has received FDA approval for YOLT-101, a groundbreaking gene-editing therapy aimed at treating familial hypercholesterolemia, marking a pivotal moment in biotechnology.

YolTech Therapeutics Achieves FDA Clearance for Revolutionary Gene-Editing Therapy YOLT-101 #Shanghai #None #Gene_Editing #YolTech #YOLT-101

Thiard News@F4F

@newsen.bsky.social

9 months ago

Weekly Update: Must-Read Health Announcements from PR Newswire This week’s recap highlights essential health press releases, covering breakthroughs in gene therapy, product approvals, and investment in healthcare innovation.

Weekly Update: Must-Read Health Announcements from PR Newswire #United_States #New_York #Gene_Editing #FDA_Approvals #Health_Press_Release

Thiard News@F4F

@newsen.bsky.social

10 months ago

CellFE and Made Scientific Join Forces to Revolutionize Non-viral Gene Editing in T Cell Therapies CellFE and Made Scientific have entered a strategic collaboration aimed at pioneering non-viral gene editing techniques for enhanced T cell therapies, making innovative treatments more widely accessible.

CellFE and Made Scientific Join Forces to Revolutionize Non-viral Gene Editing in T Cell Therapies #USA #Gene_Editing #CellFE #Made_Scientific #Alameda,_California;_Princeton,_New_Jersey

Thiard News@F4F

@newsen.bsky.social

10 months ago

AccurEdit Therapeutics to Present Groundbreaking Research at ASGCT 2025 AccurEdit Therapeutics will showcase its innovative abstracts at the 2025 ASGCT, highlighting advances in gene editing technology and its pivotal ART001 therapy.

AccurEdit Therapeutics to Present Groundbreaking Research at ASGCT 2025 #United_States #New_Orleans #Gene_Editing #AccurEdit #ART001

Thiard News@F4F

@newsen.bsky.social

10 months ago

Factor Bioscience Unveils Groundbreaking Gene Editing Innovations at ASGCT 2025 Factor Bioscience is set to present its latest non-viral gene editing advancements at the ASGCT Annual Meeting, promising to revolutionize cell therapy.

Factor Bioscience Unveils Groundbreaking Gene Editing Innovations at ASGCT 2025 #United_States #New_Orleans #CAR-T_therapy #Gene_Editing #Factor_Bioscience

Thiard News@F4F

@newsen.bsky.social

10 months ago

KII Partners with One Genomics to Advance Gene Editing Technologies Keio Innovation Initiative invests in One Genomics, a startup aiming to revolutionize gene therapy with its Safeguard gRNA Technology.

KII Partners with One Genomics to Advance Gene Editing Technologies #Japan #Tokyo #Gene_Editing #KII #One_Genomics

Norbert_R 🐘:mastodon:🦣

@norbert-renner.mastodon.social.ap.brid.gy

1 year ago

#SGU #TheSkepticsGuideToTheUniverse:
The Skeptics Guide #1026 - Mar 8 2025

Quickie with Bob: Atlantic #Shutdown; News Items: #Measles Outbreak, Reintroducing #Wolves, TIGR-Tas #Gene_Editing, #Blood_Donor Who Saved Millions Dies, #Star_Mergers; Who's That Noisy; Your Questions and E-mails […]

Thiard News@F4F

@newsen.bsky.social

1 year ago

The Projected Surge of the Global CRISPR Market Leading to $12.78 Billion by 2032 The global CRISPR market is set for significant growth, projected to reach $12.78 billion by 2032, driven by innovations and expanding applications in biotechnology.

The Projected Surge of the Global CRISPR Market Leading to $12.78 Billion by 2032 #None #biotechnology #Gene_Editing #CRISPR_Technology

Thiard News@F4F

@newsen.bsky.social

1 year ago

Innovative Collaboration Between CellFE and Syenex to Enhance Cell Engineering Methods CellFE and Syenex are collaborating to develop an advanced hybrid workflow that integrates non-viral and viral gene editing for more efficient cell therapy manufacturing.

Innovative Collaboration Between CellFE and Syenex to Enhance Cell Engineering Methods #USA #San_Francisco #Gene_Editing #CellFE #Syenex

Thiard News@F4F

@newsen.bsky.social

1 year ago

RheumaGen, Inc. Secures $15 Million Series A to Transform Autoimmune Treatment with Gene Editing RheumaGen, Inc. has launched with $15 million in Series A financing, aiming to develop innovative HLA gene-editing therapies targeting major autoimmune diseases, specifically rheumatoid arthritis.

RheumaGen, Inc. Secures $15 Million Series A to Transform Autoimmune Treatment with Gene Editing #United_States #Aurora #Autoimmune_Disease #Gene_Editing #RheumaGen

Thiard News@F4F

@newsen.bsky.social

1 year ago

Cell Therapy Technologies Market Expected to Reach $6.80 Billion by 2029 with 11% CAGR Growth The global market for Cell Therapy Technologies is projected to grow from $3.89 billion in 2023 to $6.80 billion by 2029, driven by innovations and investments.

Cell Therapy Technologies Market Expected to Reach $6.80 Billion by 2029 with 11% CAGR Growth #USA #Delray_Beach #Biopharmaceutical #Cell_Therapy #Gene_Editing

Thiard News@F4F

@newsen.bsky.social

1 year ago

Gene-Edited Pig Kidney Transplant Provides New Hope for Patients Awaiting Organ Donations An Alabama woman receives a life-saving pig kidney transplant, marking a breakthrough in organ donation technology and offering hope for others on waiting lists.

Gene-Edited Pig Kidney Transplant Provides New Hope for Patients Awaiting Organ Donations #USA #New_York_City #NYU_Langone #organ_donation #Gene_Editing

Aureliano Bombarely

@bombarelya.bsky.social

1 year ago

We switch to the #biotechnology session at the #SOL2024 with a presentation by Jae-Yean Kim who will be talking about precise #gene_editing in tomato. They have developed super-infective agrobacterium using ternary vector to increase % of transformation. HDR-GE technology is still challenging.

Frank Stassen

@frankst.bsky.social

2 years ago

De eerste behandeling met de genetische techniek crispr-cas is goedgekeurd Sikkelcelziekte: Voor het eerst is er goedkeuring voor een medische behandeling met de genetische techniek crispr-cas9. Dat is een mijlpaal. Een ernstige…

We hebben het systeem afgekeken van bacteriën, die het gebruiken om zich te verdedigen tegen fagen, maar wat een mooie tool om genetische defecten te corrigeren.
Eerste klinische trial dus binnenkort van start!
#CrisprCas9 #sikkelcelanemie #gene_editing

www.nrc.nl/nieuws/2023/...